PT Chandra Asri Pacific Tbk (PTCAY)
29.42
0.00 (0.00%)
USD |
OTCM |
Jul 05, 16:00
PT Chandra Asri Pacific Normalized PE Ratio
Normalized PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Normalized PE Ratio Data
| Date | Value |
|---|---|
| March 01, 2022 | -- |
| February 28, 2022 | -- |
| February 25, 2022 | -- |
| February 24, 2022 | -- |
| February 23, 2022 | -- |
| February 22, 2022 | -- |
| February 18, 2022 | -- |
| February 17, 2022 | -- |
| February 16, 2022 | -- |
| February 15, 2022 | -- |
| February 14, 2022 | -- |
| February 11, 2022 | -- |
| February 10, 2022 | -- |
| February 09, 2022 | -- |
| February 08, 2022 | -- |
| February 07, 2022 | -- |
| January 31, 2022 | -- |
| January 28, 2022 | -- |
| January 27, 2022 | -- |
| January 26, 2022 | -- |
| January 25, 2022 | -- |
| January 24, 2022 | -- |
| January 21, 2022 | -- |
| January 20, 2022 | -- |
| January 19, 2022 | -- |
| Date | Value |
|---|---|
| January 18, 2022 | -- |
| January 14, 2022 | -- |
| January 13, 2022 | -- |
| January 12, 2022 | -- |
| January 11, 2022 | -- |
| January 10, 2022 | -- |
| January 07, 2022 | -- |
| December 31, 2021 | -- |
| November 09, 2021 | -- |
| November 08, 2021 | -- |
| November 05, 2021 | -- |
| November 04, 2021 | -- |
| November 03, 2021 | -- |
| November 02, 2021 | -- |
| November 01, 2021 | -- |
| October 29, 2021 | -- |
| October 28, 2021 | -- |
| October 27, 2021 | -- |
| October 26, 2021 | -- |
| October 25, 2021 | -- |
| October 22, 2021 | -- |
| October 21, 2021 | -- |
| October 20, 2021 | -- |
| October 19, 2021 | -- |
| October 18, 2021 | -- |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.